TP53 Variant in the Blood of a Patient with Gastric Cancer Undergoing Tumor Profiling Tests Diagnosed as Clonal Hematopoiesis

Miki Kawai; Yuka Iijima-Yamashita; Iku Taguchi; Masato Kataoka; Masashi Sanada; Yoshiko Murakami; Chiyoe Kitagawa; Hiroyoshi Hattori

doi:10.12659/AJCR.936455

14 June 2022: Articles

Variant in the Blood of a Patient with Gastric Cancer Undergoing Tumor Profiling Tests Diagnosed as Clonal Hematopoiesis

Challenging differential diagnosis

Miki Kawai ^A , Yuka Iijima-Yamashita ^C , Iku Taguchi ^B , Masato Kataoka ^A , Masashi Sanada ^C , Yoshiko Murakami ^B , Chiyoe Kitagawa ^B , Hiroyoshi Hattori ^A*

DOI: 10.12659/AJCR.936455

Am J Case Rep 2022; 23:e936455

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 1. Sequencing analysis of the TP53 gene in the patient. a), b), and c) represent fingernails, blood, and buccal swab, respectively. The pathogenic variant was detected in the blood and the buccal swab, but not in the fingernail.

Back to the Article

Variant in the Blood of a Patient with Gastric Cancer Undergoing Tumor Profiling Tests Diagnosed as Clonal Hematopoiesis

Your Privacy